Jun 16, 2019
A French laboratory believes it has discovered a new way to detect ‘microdoses’ of erythropoietin (EPO).
The Châtenay-Malabry laboratory, which developed the first test for the detection of EPO 20 years ago, said the new test could show traces of the drug 48-hours after it’s been administered, as opposed to the current 24-hour window.
It is believed that microdoses – which have to be taken every two days to have an effect – have been used since the first EPO test was developed, allowing users to gain a performance benefit without being caught.
These microdoses may also allow blood levels to stay high, after they’ve been artificially raised.